Publicaciones en colaboración con investigadores/as de Universidad Politécnica de Valencia (36)

2024

  1. Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption processes using PhysPK®

    Computer Methods and Programs in Biomedicine, Vol. 243

2023

  1. Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 9, pp. 2691-2702

  2. Commonly used methods for dissolution profile comparison

    Time-Proof Perspectives on Bioequivalence (Nova Science Publishers, Inc.), pp. 297-322

2022

  1. Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis

    Pharmaceutics, Vol. 14, Núm. 3

  2. Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics

    European Journal of Pharmaceutical Sciences, Vol. 174

2021

  1. Estimators and confidence intervals of f2 using bootstrap methodology for the comparison of dissolution profiles

    Computer Methods and Programs in Biomedicine, Vol. 212

  2. Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 3, pp. 905-915

  3. In vitro skin penetration of bronidox, bronopol and formaldehyde from cosmetics

    Regulatory Toxicology and Pharmacology, Vol. 122

2020

  1. A multilevel object-oriented modelling methodology for physiologically-based pharmacokinetics (PBPK): Evaluation with a semi-mechanistic pharmacokinetic model

    Computer Methods and Programs in Biomedicine, Vol. 189

  2. Erratum: Assessment of the inter-batch variability of microstructure parameters in topical semisolids and impact on the demonstration of equivalence (Pharmaceutics, (2019) 11, 10.3390/pharmaceutics11100503)

    Pharmaceutics

  3. Influence of inter-and intra-batch variability on the sample size required for demonstration of equivalent microstructure of semisolid dosage forms

    Pharmaceutics, Vol. 12, Núm. 12, pp. 1-15

2019

  1. Assessment of the inter-batch variability of microstructure parameters in topical semisolids and impact on the demonstration of equivalence

    Pharmaceutics, Vol. 11, Núm. 10

  2. Development of antibiotic loaded biodegradable matrices to prevent superficial infections associated to total knee arthroplasty

    Colloids and Surfaces B: Biointerfaces, Vol. 181, pp. 1-5

  3. Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac

    International Journal of Pharmaceutics, Vol. 572

2018

  1. Investigation of different iontophoretic currents profiles for short-term applications in cosmetics

    Pharmaceutics, Vol. 10, Núm. 4

  2. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen

    European Journal of Pharmaceutical Sciences, Vol. 115, pp. 119-125

  3. Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

    Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 1, pp. 65-71

2017

  1. Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement

    Orthopaedic Surgery, Vol. 9, Núm. 4, pp. 331-341

  2. Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty

    Journal of Arthroplasty, Vol. 32, Núm. 10, pp. 3126-3133.e1

  3. Population pharmacokinetics of lenalidomide in multiple myeloma patients

    Cancer Chemotherapy and Pharmacology, Vol. 79, Núm. 1, pp. 189-200